The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials

por Dahlöf, Carl, Loder, Elizabeth, Diamond, Merle, Rupnow, Marcia, Papadopoulos, George, Mao, Lian
Publicado 2007

Eptinezumab for the prevention of chronic migraine: efficacy and safety through 24 weeks of treatment in the phase 3 PROMISE-2 (Prevention of migraine via intravenous ALD403 safety...

por Silberstein, Stephen, Diamond, Merle, Hindiyeh, Nada A., Biondi, David M., Cady, Roger, Hirman, Joe, Allan, Brent, Pederson, Susan, Schaeffler, Barbara, Smith, Jeff
Publicado 2020

Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medicat...

por Marmura, Michael J., Diener, Hans‐Christoph, Cowan, Robert P., Tepper, Stewart J., Diamond, Merle L., Starling, Amaal J., Hirman, Joe, Mehta, Lahar, Brevig, Thomas, Cady, Roger
Publicado 2021